Domesco Medical Import - Export Past Earnings Performance
Past criteria checks 1/6
Domesco Medical Import - Export's earnings have been declining at an average annual rate of -4.2%, while the Pharmaceuticals industry saw earnings growing at 8.3% annually. Revenues have been growing at an average rate of 4.8% per year. Domesco Medical Import - Export's return on equity is 12%, and it has net margins of 8.3%.
Key information
-4.2%
Earnings growth rate
-4.2%
EPS growth rate
| Pharmaceuticals Industry Growth | 13.0% |
| Revenue growth rate | 4.8% |
| Return on equity | 12.0% |
| Net Margin | 8.3% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Domesco Medical Import - Export makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 1,797,834 | 149,990 | 192,176 | 0 |
| 30 Jun 24 | 1,794,626 | 161,819 | 194,607 | 0 |
| 31 Mar 24 | 1,732,711 | 171,856 | 194,488 | 0 |
| 31 Dec 23 | 1,719,032 | 155,833 | 188,657 | 0 |
| 30 Sep 23 | 1,685,185 | 173,124 | 188,793 | 0 |
| 30 Jun 23 | 1,639,680 | 177,652 | 193,116 | 0 |
| 31 Mar 23 | 1,639,004 | 175,596 | 211,182 | 0 |
| 31 Dec 22 | 1,592,727 | 170,064 | 218,405 | 0 |
| 30 Sep 22 | 1,614,661 | 158,589 | 232,778 | 0 |
| 30 Jun 22 | 1,603,020 | 148,277 | 229,559 | 0 |
| 31 Mar 22 | 1,567,268 | 138,996 | 220,133 | 0 |
| 31 Dec 21 | 1,498,395 | 143,354 | 215,211 | 0 |
| 30 Sep 21 | 1,484,876 | 134,517 | 228,030 | 0 |
| 30 Jun 21 | 1,427,686 | 122,723 | 234,666 | 0 |
| 31 Mar 21 | 1,451,951 | 153,518 | 238,633 | 0 |
| 31 Dec 20 | 1,451,954 | 161,582 | 235,290 | 0 |
| 30 Sep 20 | 1,428,250 | 181,064 | 231,832 | 0 |
| 30 Jun 20 | 1,471,638 | 212,794 | 244,202 | 0 |
| 31 Mar 20 | 1,449,060 | 202,017 | 228,329 | 0 |
| 31 Dec 19 | 1,468,390 | 209,371 | 225,786 | 0 |
| 30 Sep 19 | 1,459,919 | 210,793 | 211,982 | 0 |
| 30 Jun 19 | 1,419,657 | 207,367 | 195,925 | 0 |
| 31 Mar 19 | 1,402,421 | 207,269 | 216,216 | 0 |
| 31 Dec 18 | 1,385,088 | 211,614 | 225,069 | 0 |
| 30 Sep 18 | 1,365,586 | 197,323 | 274,390 | 0 |
| 30 Jun 18 | 1,368,590 | 193,089 | 290,440 | 0 |
| 31 Mar 18 | 1,353,255 | 190,740 | 297,249 | 0 |
| 31 Dec 17 | 1,339,651 | 195,202 | 294,420 | 0 |
| 30 Sep 17 | 1,340,803 | 189,490 | 293,118 | 0 |
| 30 Jun 17 | 1,310,141 | 185,022 | 288,348 | 0 |
| 31 Mar 17 | 1,288,909 | 181,457 | 281,762 | 0 |
| 31 Dec 16 | 1,289,294 | 168,641 | 291,610 | 0 |
| 30 Sep 16 | 1,269,096 | 167,424 | 255,848 | 0 |
| 30 Jun 16 | 1,277,743 | 154,057 | 248,619 | 0 |
| 31 Mar 16 | 1,253,665 | 132,782 | 236,828 | 0 |
| 31 Dec 15 | 1,234,031 | 125,146 | 225,410 | 0 |
| 30 Sep 15 | 1,245,606 | 94,986 | 224,600 | 0 |
| 30 Jun 15 | 1,260,436 | 92,664 | 230,183 | 0 |
| 31 Mar 15 | 1,370,943 | 102,389 | 250,299 | 0 |
| 31 Dec 14 | 1,486,060 | 104,908 | 262,857 | 0 |
| 30 Sep 14 | 1,525,259 | 127,916 | 278,588 | 0 |
| 30 Jun 14 | 1,562,392 | 123,018 | 284,080 | 0 |
| 31 Mar 14 | 1,516,156 | 113,457 | 285,142 | 0 |
| 31 Dec 13 | 1,429,609 | 107,520 | 278,392 | 0 |
Quality Earnings: DMC has high quality earnings.
Growing Profit Margin: DMC's current net profit margins (8.3%) are lower than last year (10.3%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: DMC's earnings have declined by 4.2% per year over the past 5 years.
Accelerating Growth: DMC's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: DMC had negative earnings growth (-13.4%) over the past year, making it difficult to compare to the Pharmaceuticals industry average (-13%).
Return on Equity
High ROE: DMC's Return on Equity (12%) is considered low.